Judge OKs Class-Action Suit From Allergan Investors
The lawsuit says that Allergan repeatedly downplayed the cancer risk its textured breast implants posed as compared to those from other manufacturers.
You may also be interested in...
Allergan PLC announced that it would take its Biocell textured breast implants and tissue expanders off the market worldwide shortly after the US FDA released additional information linking the use of the implants to a rare cancer.
Virtual and in-person events are planned for Washington, DC, and Minneapolis, MN, during the trade group gathering.
The US patent office has upheld all seven patents at issue, with the verdict on the final three having come on 22 September.